L Trademark

Trademark Overview


On Wednesday, April 26, 2017, a trademark application was filed for L with the United States Patent and Trademark Office. The USPTO has given the L trademark a serial number of 87425805. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Saturday, January 27, 2018. This trademark is owned by SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.. The L trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, fo...
l

General Information


Serial Number87425805
Word MarkL
Filing DateWednesday, April 26, 2017
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateSaturday, January 27, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a hexagon or cube shape formed by three L shapes of equal size. The top and bottom-right L shapes form an outward point, with the bottom-left L shape flipped, with the point going inward.
Goods and ServicesPharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
Pseudo MarkLLL
Pseudo MarkL L L

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateSaturday, January 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFutian Dist. Shenzhen 518040
CN

Party NameSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFutian Dist. Shenzhen 518040
CN

Trademark Events


Event DateEvent Description
Monday, January 29, 2018ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Saturday, January 27, 2018ABANDONMENT - AFTER INTER PARTES DECISION
Saturday, January 27, 2018OPPOSITION TERMINATED NO. 999999
Saturday, January 27, 2018OPPOSITION SUSTAINED NO. 999999
Thursday, October 19, 2017OPPOSITION INSTITUTED NO. 999999
Thursday, October 19, 2017OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 27, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, July 27, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 27, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, July 27, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, July 24, 2017ASSIGNED TO EXAMINER
Thursday, May 4, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 29, 2017NEW APPLICATION ENTERED IN TRAM